跳至主要内容
临床试验/CTRI/2025/02/080682
CTRI/2025/02/080682尚未招募Phase 3 4

Nebulized levosalbutamol versus combination of magnesium sulphate and levosalbutamol nebulization in acute bronchial asthma

Shyam Shah medical college1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年2月27日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
Reassessment of vitals heart rate,respiratory rate,saturation,Glass Gow Coma scale and peak expiratory flow metre at baseline and after 2 hours.

研究概览

简要总结

Nebulized bronchodilator which will be levosalbutamol in group A in the form of 4 doses of nebulized solution 0.5g% 20 minutes apart and magnesium sulphate in group B in the form of 2 doses nebulized solution 10g% with 4 doses of nebulized levosalbutamol 20 minutes apart.

Reassessment of the patients will be performed after 2 hours to detect improvement.

研究设计

研究类型
Interventional

入排标准

年龄范围
2.00 Year(s) 至 15.00 Year(s)(—)
性别
All

入选标准

  • Patients newly diagnosed or known cases of bronchial asthma,aged 2-15 years are Nebulized bronchodilator which will be levosalbutamol in group (A) in the form of 4 doses of nebulized solution 0.5 gm% (each dose 1 ml containing 5 mg levosalbutamol) twenty minutes apart and magnesium sulphate in group (B) in the form of 2 doses of nebulized solution 10 gm% (each dose 1 ml containing 100 mg magnesium sulphate) twenty minutes apart with 4 doses of nebulized solution 0.5 gm percent (each dose 1ml containing 5 mg levosalbutamol) twenty minutes apart Reassessment of the patients will be performed after 2 hours to detect improvement.

排除标准

  • 1.Fever 2.Smoker 3.COPD patients 4.Pneumonia 5.Cardiac,renal or hepatic insufficiency 6.Respiratory failure.

结局指标

主要结局

Reassessment of vitals heart rate,respiratory rate,saturation,Glass Gow Coma scale and peak expiratory flow metre at baseline and after 2 hours.

时间窗: Reassessment of vitals heart rate,respiratory rate,saturation,Glass Gow Coma scale and peak expiratory flow metre at baseline and after 2 hours.

次要结局

  • Duration of stay in intensive care unit.(Duration of hospital stay)

研究者

发起方
Shyam Shah medical college
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Asha B D

Shyam Shah medical college

研究点 (1)

Loading locations...

相似试验